Tianjin Medical University General Hospital

Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection

No phase, Not yet recruiting, 2026, 220 people, clinicaltrials.gov

Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)

Collaborator, Phase 3, Withdrawn, 2024, 0 people, 19 Aug 2024, clinicaltrials.gov

NCT06457074

Collaborator, Phase 4, Completed, 2024, 306 people, 13 Jun 2024, clinicaltrials.gov

NCT06452537

Phase 2/3, Active, not recruiting, 2024, 102 people, 11 Jun 2024, clinicaltrials.gov

NCT06327451

Phase 2, Recruiting, 2024, 50 people, 25 Mar 2024, clinicaltrials.gov

NCT06288373

Collaborator, Phase 2/3, Recruiting, 2024, 440 people, 1 Mar 2024, clinicaltrials.gov

NCT06288360

Collaborator, Phase 2, Recruiting, 2024, 40 people, 1 Mar 2024, clinicaltrials.gov

NCT06078839

Collaborator, Phase 4, Status unknown, 2023, 778 people, 12 Oct 2023, clinicaltrials.gov

NCT05909943

Phase 1/2, Withdrawn, 2024, 0 people, 18 Jun 2023, clinicaltrials.gov

NCT05196945

Collaborator, Phase 4, Status unknown, 2022, 316 people, 19 Jan 2022, clinicaltrials.gov

NCT03790085

Early phase 1, Status unknown, 2018, 2,700 people, 31 Dec 2018, clinicaltrials.gov

NCT03580239

Collaborator, Phase 3, Status unknown, 2019, 120 people, 9 Jul 2018, clinicaltrials.gov

NCT03350633

Phase 2/3, Completed, 2017, 118 people, 22 Nov 2017, clinicaltrials.gov

NCT03342807

Collaborator, Phase 4, Status unknown, 2017, 220 people, 17 Nov 2017, clinicaltrials.gov

NCT02878772

Phase 2/3, Completed, 2014, 60 people, 25 Aug 2016, clinicaltrials.gov

NCT01670890

Collaborator, Phase 2, Status unknown, 2012, 120 people, 22 Aug 2012, clinicaltrials.gov

Association of metabolic phenotypes with multimorbidity and age-stratified analysis in physical examination population

Chinese Journal of Geriatrics, 10 Oct 2026